A comprehensive view of biontech se. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia: BioNTech SE Receives Patent for 'Dose determination for immunotherapeutic agents'
Published: April 19, 2024 by Australian Government
Biontech SE Seeks Patent for Process for the Preparation of a Substituted Imidazoquinoline
Published: April 18, 2024 by Chemical Patent News
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "RNA CONSTRUCTS AND USES THEREOF"
Published: April 17, 2024 by U.S. Fed News
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published: April 15, 2024 by FiercePharma
INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "RNA COMPOSITIONS TARGETING CLAUDIN-18.2"
Published: April 14, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count